|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
DESOGESTREL AND ETHINYL ESTRADIOL
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
X
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
melasma |
|
menstrual irregularity |
|
migraine |
|
myocardial infarction |
|
nausea/vomiting |
|
optic neuritis |
|
pancreatitis |
|
peliosis hepatis |
|
photosensitivity |
|
pulmonary embolism |
|
retinal thrombosis |
|
secondary malignancy |
|
stroke |
|
thromboembolism |
|
thrombosis |
|
urticaria |
|
vaginal bleeding |
|
vaginitis |
|
weight gain |
|
abdominal pain |
|
acne vulgaris |
|
alopecia |
|
amenorrhea |
|
anorexia |
|
anxiety |
|
appetite stimulation |
|
azotemia |
|
breakthrough bleeding |
|
breast discharge |
|
breast enlargement |
|
candidiasis |
|
cervical dysplasia |
|
cholecystitis |
|
cholelithiasis |
|
cholestasis |
|
depression |
|
diplopia |
|
edema |
|
elevated hepatic enzymes |
|
erythema nodosum |
|
fluid retention |
|
galactorrhea |
|
gingivitis |
|
headache |
|
hepatitis |
|
hepatoma |
|
hypertension |
|
jaundice |
|
keratoconus |
|
libido decrease |
|
maculopapular rash |
|
mastalgia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
acquired immunodeficiency syndrome (AIDS) |
|
breast-feeding |
|
children |
|
cholestasis |
|
contact lenses |
|
depression |
|
diabetes mellitus |
|
gallbladder disease |
|
headache |
|
human immunodeficiency virus (HIV) infection |
|
hypercalcemia |
|
hypercholesterolemia |
|
hyperlipidemia |
|
hypertension |
|
hypertriglyceridemia |
|
hypothyroidism |
|
incomplete abortion |
|
menstrual irregularity |
|
migraine |
|
obesity |
|
obstetric delivery |
|
ocular disease |
|
porphyria |
|
renal disease |
|
surgery |
|
systemic lupus erythematosus (SLE) |
|
thyroid disease |
|
tobacco smoking |
|
|
ADULT DOSE:
|
|
Contraceptive, systemic or
Estrogen-progestin or
[Antiendometriotic agent] or
[Gonadotropin inhibitor, female, noncontraceptive use] -Twenty-one-day cycle: Oral, 1 tablet a day for twenty-one days commencing on Day 1 of the menstrual cycle or on the first Sunday after the menstrual cycle begins; the next round of treatment is begun on the eighth day after the last tablet of the previous cycle has been taken.
Twenty-eight-day cycle: Oral, 1 tablet a day for twenty-eight days commencing on Day 1 of the menstrual cycle, or on the first Sunday after the menstrual cycle begins; the next round of treatment is begun on the day after the last tablet of the previous cycle has been taken.
Note: With a Sunday start schedule, the patient should take her first tablet on the first Sunday after the onset of menstruation. If the patient's period begins on a Sunday, she should take her first tablet that same day.
With a Day-1 start schedule, the patient should take her first tablet on Day 1 of the menstrual cycle.
The last seven tablets of the twenty-eight-day cycle contain no hormones. These seven companion tablets are a different color from those containing hormones.
Oral contraceptives may be given continuously or cyclically for endometriosis. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|